Updated Data Matrix Available

Market Value | Market Volume | Epidemiology | Clinical Trials | Patent Landscape | Regulatory Approvals

Knee Cartilage Repair Market by Procedure [Chondrocyte Implantation (Autologous Chondrocyte Implantation, Matrix-Induced Autologous Chondrocyte Implantation, Autologous Matrix-Induced Chondrogenesis / Enhanced Microfracture, by Product (BST-CarGel, GelrinC, JointRep, CartiFill, chondrotissue, Chondro-Gide, MeRG, Hyalofast, ChondroFiller), Others (DeNovo NT Graft)], Osteochondral Autograft Transfer, Osteochondral Allograft Transplantation, Arthroscopic Chondroplasty, Partial Knee Replacement, Microfracture, Others (Meniscus Repair)] and Forecast 2024-2031

$3,000.00

Report Specifications: Market Size, Market Share, Growth Trends, Forecast, Geography

Articular cartilage is the soft white cartilage that covers the ends of the bones and helps joints to move smoothly.  It also helps to absorb the forces throughout the knee. Early identification and treatment of articular cartilage damage can have a significant effect on outcomes for patients.

X-rays are sometimes useful but an MRI scan provides doctors with the best pictures of the knee cartilages. By repairing or replacing the damaged cartilage before it completely wears out, the arthritic damage can be reversed and the joints preserved. With improvements to arthroscopes and higher resolution cameras, the procedure has become extremely effective for both the diagnosis and treatment of knee problems.

The global knee cartilage repair market report provides market size ($million 2021 to 2031), market volume (number of procedures), market share and forecast (CAGR%, 2024 to 2031).

The global knee cartilage repair market segmentation is based on procedure [chondrocyte implantation (autologous chondrocyte implantation, matrix-induced ACI, autologous matrix-induced chondrogenesis or enhanced microfracture by product, others), osteochondral grafts transplantation (osteochondral autograft transfer, osteochondral allograft transplantation, arthroscopic chondroplasty, partial knee replacement / partial knee arthroplasty, microfracture, others (meniscus repair), and geography.

Additionally, the global market size for the autologous matrix-induced chondrogenesis (AMIC) or enhanced microfracture (EMFx) products has been provided for BST-CarGel, GelrinC, JointRep, CartiFill, chondrotissue, Chondro-Gide, MeRG, Hyalofast, and ChondroFiller.

The global knee cartilage repair market research report is divided by geography (regional and country based) into North America (U.S., Canada), Latin America (Brazil, Mexico, Rest of LA), Europe (U.K., Germany, France, Italy, Spain, Rest of EU), Asia Pacific (Japan, China, India, Rest of APAC), and Rest of the World.

The global knee cartilage repair market report also provides the detailed market landscape (market drivers, restraints, opportunities), market attractiveness analysis and profiles of major competitors in the global market including company overview, financial snapshot, key products, technologies and services offered, and recent developments.

Major players operating in global knee cartilage repair market and included in the report are B. Braun Melsungen AG, , Histogenics Corporation, ISTO Biologics, Inc., Johnson & Johnson (DePuy Synthes), MEDIPOST Co., Ltd., Smith & Nephew plc (Osiris Therapeutics, Inc.), Stryker Corporation, Takeda Pharmaceutical Co. Ltd. (TiGenix N.V.), Vericel Corporation, and Zimmer Biomet.

DATA INCLUDED: Knee Cartilage Repair Market Size, Knee Cartilage Repair Market Share, Knee Cartilage Repair Market Growth Rates, Knee Cartilage Repair Market Trends, and Knee Cartilage Repair Market Forecast to 2031

Market Data:

  • Base year for estimation: 2023
  • Actual estimates/Historical data: 2021-2031
  • Forecast period: 2024-2031
  • Market representation: Revenue in $million and CAGR % from 2024 to 2031
  • Regional scope: North America, Europe, Asia Pacific, Latin America, Rest of the World (Middle East & Africa)
  • Country scope: U.S., Canada, U.K., Germany, France, Italy, Spain, Japan, China, India, South Korea, Brazil, Mexico, South Africa, South Korea, Saudi Arabia, UAE and others.
  • Report coverage: Revenue forecast, company share, competitive landscape, growth factors, and trends
  • 15% free customization scope: Any specific or custom requirements, which is not currently within the scope of the report, will be provided as a part of customization.

Qualitative Analysis:

  • Industry overview
  • Industry trends
  • Market drivers and restraints
  • Key market opportunities
  • Market size
  • Growth trends
  • Porter’s five forces analysis
  • Market attractiveness analysis
  • Competitive landscape
    • Company overview
    • Financial performance
    • Product portfolio
    • Strategic insights
    • Recent developments

Quantitative Analysis:

  • Market size estimates and forecast for all segments
  • Regional market size estimated and forecast for major countries
  • Company financial performance
  • Competitive landscape: Company market share analysis

Please contact us for offers on individual or multiple report purchases.

  1. Introduction
  2. Executive Summary
    • Market Size Estimation ($million, 2021-2031)
    • Forecast Estimation ($million and CAGR%, 2024-2031)
  3. Research Methodology
  4. Market Landscape
    • Market Dynamics
      • Drivers
      • Barriers
      • Opportunities
    • Market Share Analysis
      • Companies
      • Devices
    • Market Trends Analysis
      • Key success factors
      • Market Growth Rate
    • Market Attractiveness Analysis
    • Market Profitability Analysis
      • Buyer power
      • Supplier power
      • Barriers to entry
      • Threat of substitute products
      • Rivalry among firms in the industry
    • Distribution Channels
  5. Market Segmentation [refer Market Segments and Companies Tab]
    • Device or Brand Type
    • Diagnostic Test
    • Indication Type
    • Technology
    • Diagnostics, Therapeutic or Surgical Application
    • End User Groups
  6. Geography (Region, Country)
    • North America (U.S., Canada)
    • Europe (U.K., Germany, France, Italy, Spain, Rest of EU)
    • Asia Pacific (Japan, China, India, Rest of APAC)
    • Latin America (Brazil, Mexico, Rest of LA)
    • Rest of the World (Middle East & Africa)
  7. Regulatory Overview 
    • Device Classification I, II, III, IV
    • Device (FDA, EMEA) Approvals
  8. Company Profiles [refer Market Segments and Companies Tab]
    • Company Overview
    • Financial Snapshot
    • Product Portfolio
    • Business Strategies
    • Recent Developments
  9. Recommendations
  10. References

Key Questions Answered:
1. What are the factors driving and limiting this market, key success factors and challenges?
2. Which are the leading competitors in the market, their market share, profitability and key trends by product, technology, services portfolio?
3. How do markets perform between countries and regions?
4. What market segments are contributing to maximum share and greatest growth?
5. What are the product or procedure volumes by country and regions?

Actionable Insights Included:
1. Product portfolio matrix (Share vs. Growth)
2. Market attractiveness (Region vs. Growth)
3. Spot matrix (Product vs. Region)
4. Geographic distribution matrix (Share vs. Growth)

Knee Cartilage Repair Market

1. Procedure
1.1. Chondrocyte Implantation
1.1.1. Autologous Chondrocyte Implantation (ACI)
1.1.2. Matrix-induced ACI (MACI)
1.1.3. Autologous Matrix-Induced Chondrogenesis (AMIC) / Enhanced Microfracture (EMFx), by Product
1.1.4. Others (DeNovo NT Graft)
1.2. Osteochondral Grafts Transplantation
1.2.1. Osteochondral Autograft Transfer (OAT)
1.2.2. Osteochondral Allograft Transplantation (OCA)
1.3. Arthroscopic Chondroplasty
1.4. Partial Knee Replacement (PKR) / Partial Knee Arthroplasty (PKA)
1.5. Microfracture
1.6. Others (Meniscus Repair)

2. Geography
2.1. North America (U.S., Canada)
2.2. Europe (U.K., Germany, France, Italy, Spain, Rest of EU)
2.3. Asia Pacific (Japan, China, India, Rest of APAC)
2.4. Latin America (Brazil, Mexico, Rest of LA)
2.5. Rest of the World

3. Company Profiles
3.1. B. Braun Melsungen AG
3.2. Histogenics Corporation
3.3. ISTO Biologics, Inc.
3.4. Johnson & Johnson (DePuy Synthes)
3.5. MEDIPOST Co., Ltd.
3.6. Smith & Nephew plc (Osiris Therapeutics, Inc.)
3.7. Stryker Corporation
3.8. Takeda Pharmaceutical Co. Ltd. (TiGenix N.V.)
3.9. Vericel Corporation
3.10. Zimmer Biomet

    Request ToC / Sample Report

    Full Name*

    Company Email*

    Phone Number* [Please add country code]

    Subject*

    Message*

    Secure Online Payment

    iHealthcareAnalyst, Inc.

    Contact Address

    US Office: 2109, Mckelvey Hill Drive, Maryland Heights, MO 63043, United States
    Phone: +1 (314) 315-4764
    India Office: 5, Shilpa Chambers, Opp. J. M. Road, Shivajinager, Pune 411005, India
    Phone: +91 (20) 25898524
    Email: sales@ihealthcareanalyst.com